Page last updated: 2024-12-09

cardamonin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cardamonin: found in Zingiberaceae; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID641785
CHEMBL ID378104
CHEBI ID125601
CHEBI ID186253
SCHEMBL ID449220
MeSH IDM0401656

Synonyms (60)

Synonym
(e)-1-(2,4-dihydroxy-6-methoxy-phenyl)-3-phenyl-prop-2-en-1-one
cardamonin
NCGC00180767-01
MEGXP0_000534
ACON1_000221
(2e)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one
2'4'-dihydroxy-6'-methoxy-chalcone
inchi=1/c16h14o4/c1-20-15-10-12(17)9-14(19)16(15)13(18)8-7-11-5-3-2-4-6-11/h2-10,17,19h,1h3/b8-7
1-(2\\',4\\'-dihydroxy-6\\'-methoxy-phenyl)-3-phenyl-propenone
2-propen-1-one, 1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenyl-, (2e)-
smr000440601
MLS000876992
LMPK12120245
CHEBI:125601
bdbm50185446
BRD-K61559475-001-01-0
1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one
cardamomin
CHEMBL378104 ,
19309-14-9
CHEBI:186253
(e)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one
unii-h8kp1oj8jx
dihydroxymethoxychalcone
alpinetin chalcone
2',4'-dihydroxy-6'-methoxychalcone
(e)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenyl-2-propen-1-one
h8kp1oj8jx ,
A813330
18956-16-6
(e)-1-(2,4-dihydroxy-6-methoxy-phenyl)-3-phenyl-propenone
HMS2271N04
S3867
(2e)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenyl-2-propen-1-one
phyto-dkk1
dihydroxymethoxychalcone [inci]
AKOS015896716
CCG-208127
SCHEMBL449220
Q-100234
cardamonin, >=98% (hplc)
(e)-cardamoni
(e)-cardamonin
J-012229
ncgc00180767-02!(e)-1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenylprop-2-en-1-one
HY-N0279
Q5038242
mfcd00238554
DB14122
DS-15713
cardamonin ,(s)
2-propen-1-one, 1-(2,4-dihydroxy-6-methoxyphenyl)-3-phenyl-
cardamomin; alpinetin chalcone
(e)-cardamomin; (e)-alpinetin chalcone
CS-0008777
cardamoni
AC-34864
DTXSID201029726
cardamomin;alpinetin chalcone
Z2315575709

Research Excerpts

Overview

Cardamonin is a naturally occurring chalcone, majorly from the Zingiberaceae family, which includes a wide range of spices from India. Cardamonin (CAD) is a member of the aromatic ketones family that is closely related to anti-bacterial, anti-inflammatory and anti-cancer effects.

ExcerptReferenceRelevance
"Cardamonin is a novel anticancer chalcone which exhibits a wide range of pharmacological activities."( Cardamonin inhibits the expression of P-glycoprotein and enhances the anti-proliferation of paclitaxel on SKOV3-Taxol cells.
Chen, H; Ding, Q; Niu, P; Shi, D; Zhu, Y, 2022
)
2.89
"Cardamonin is a spice component that exerts anti-inflammatory and anti-oxidative properties against pulmonary inflammation."( Cardamonin attenuates phorbol 12-myristate 13-acetate-induced pulmonary inflammation in alveolar macrophages.
Chang, PC; Chen, JH; Chen, YC; Cheng, YK; Tsai, CF; Wang, TK; Wu, CY; Yeh, WL, 2022
)
2.89
"Cardamonin is a chalcone with neuroprotective activity. "( Cardamonin attenuates cerebral ischemia/reperfusion injury by activating the HIF-1α/VEGFA pathway.
Li, J; Ni, H; Zheng, J; Zhou, B, 2022
)
3.61
"Cardamonin (CAR) is a substance found in the fruit of the chasteberry plant and has anti-inflammatory and anti-tumor activities."( Cardamonin protects against iron overload induced arthritis by attenuating ROS production and NLRP3 inflammasome activation via the SIRT1/p38MAPK signaling pathway.
Chen, B; Chen, C; Chen, J; Dou, X; He, Q; Li, M; Li, S; Lin, Y; Pan, Z; Wang, F; Wang, H; Wang, X; Xiao, J; Zeng, J, 2023
)
3.07
"Cardamonin (CAD) is a flavonoid with talented antioxidant, anti-inflammatory capacity, and satisfactory biosafety."( Nephroprotective Effects of Cardamonin on Renal Ischemia Reperfusion Injury/UUO-Induced Renal Fibrosis.
Chen, ZY; Huang, S; Jiang, Z; Liu, XH; Wang, L; Zhang, B, 2023
)
1.93
"Cardamonin (CAD) is a member of the aromatic ketones family that is closely related to anti-bacterial, anti-inflammatory and anti-cancer effects. "( Cardamonin attenuates chronic inflammation and tumorigenesis in colon.
Hou, S; Huang, G; Liu, B; Yu, N; Yuan, Q; Yuan, X, 2019
)
3.4
"Cardamonin (CADMN) is a natural bioactive chalcone found in several edible plants such as cardamom and"( Antiproliferative and Apoptotic Effects of Cardamonin against Hepatocellular Carcinoma HepG2 Cells.
Abdul Majid, N; Alshawsh, MA; Badroon, NA, 2020
)
1.54
"Cardamonin (CAR) is a chalcone extracted from Alpinia katsumadai and other plants."( Cardamonin protects nucleus pulposus cells against IL-1β-induced inflammation and catabolism via Nrf2/NF-κB axis.
Chen, J; Gao, W; Huang, C; Li, J; Ma, H; Shao, Z; Shi, Y; Sun, L; Tian, N; Wang, B; Wang, X; Wu, A; Wu, H; Wu, Y; Xie, C; Zhang, X; Zhou, Y, 2021
)
2.79
"Cardamonin is a naturally occurring chalcone, majorly from the Zingiberaceae family, which includes a wide range of spices from India. "( Cardamonin Attenuates Experimental Colitis and Associated Colorectal Cancer.
Aparna, JS; Athira, SR; Babu, A; Harikumar, KB; James, S; Kumar, SS; Lankadasari, MB; Mohammed, S; Namitha, NN; Paul, AM; Reshmi, G; Vijayan, Y, 2021
)
3.51
"Cardamonin (CDN) is an anti-inflammatory molecule and a novel iNOS inhibitor, and Nω-Nitro-L-arginine (L-NNA) is a NOS inhibitor."( Effect of cardamonin on hepatic ischemia reperfusion induced in rats: Role of nitric oxide.
Abdel-Mottaleb, Y; Atef, Y; El-Fayoumi, HM; Mahmoud, MF, 2017
)
1.58
"Cardamonin is a spice derived nutraceutical and herein, for the first time we evaluated the therapeutic benefits of cardamonin in Azoxymethane (AOM) induced mouse model of colorectal cancer."( Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression.
Aparna, JS; Binu, VS; Harikumar, KB; James, S; Lankadasari, MB; Mohammed, S; Paul, AM; Reshmi, G; Santhoshkumar, TR, 2017
)
2.62
"Cardamonin is a naturally occurring chalcone from Alpinia species exhibiting anti-inflammatory effects."( Differential regulation of MyD88- and TRIF-dependent signaling pathways of Toll-like receptors by cardamonin.
Heo, S; Kim, AY; Kim, SY; Shim, HJ; Youn, HS, 2018
)
1.42
"Cardamonin is a chalconoid isolated from various herbs, such as Alpinia katsumadai and Carya cathayensis Sarg. "( Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation.
Chen, SH; Ding, B; Ding, ZS; Jin, B; Lu, JJ; Shen, YJ; Yang, X; Zhu, XX, 2014
)
3.29
"Cardamonin is a chalcone isolated from Alpinia katsumadai. "( Anti-inflammatory activities of cardamonin from Alpinia katsumadai through heme oxygenase-1 induction and inhibition of NF-κB and MAPK signaling pathway in the carrageenan-induced paw edema.
Deng, JS; Huang, GJ; Huang, SS; Lee, MM; Li, YY, 2015
)
2.14
"Cardamonin is a chalcone that exhibits anti-tumor activity."( Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity.
Chen, YY; Deng, J; Liu, Y; Niu, PG; Shi, DH; Zhang, YX, 2015
)
2.58
"Cardamonin is a naturally occurring chalcone with strong anti-inflammatory activity. "( The anti-inflammatory effect and potential mechanism of cardamonin in DSS-induced colitis.
Deng, C; Dou, W; Mani, S; Ren, G; Sun, A; Wang, Z; Wei, X; Wu, X; Zhang, J, 2015
)
2.11
"Cardamonin is a natural chalcone derivative with considerable anti-inflammatory activity."( Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats.
Abd Al Haleem, EN; Ali, AA; Khaleel, SA; Sallam, AS, 2017
)
1.5

Effects

Cardamonin (CAD) has been demonstrated to possess antioxidant and anti-inflammatory properties in several diseases. Cardamonin has promising potential in cancer prevention and therapy by interacting with proteins.

ExcerptReferenceRelevance
"Cardamonin has a protective effect against acetic acid-induced colitis. "( Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats.
Abd Al Haleem, EN; Ali, AA; Khaleel, SA; Sallam, AS, 2017
)
2.22
"Cardamonin (CAD) has been demonstrated to possess antioxidant and anti-inflammatory properties in several diseases, whether CAD may influence the OA progression is still obscure."( Cardamonin alleviates chondrocytes inflammation and cartilage degradation of osteoarthritis by inhibiting ferroptosis via p53 pathway.
Gong, Z; Hu, Y; Li, L; Li, X; Qiu, B; Wang, Y, 2023
)
3.07
"Cardamonin has been demonstrated to have an inhibitory effect in many cancers, but its underlying mechanism remains elusive. "( Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma.
Huang, B; Huang, J; Li, Y; Qin, Y; Wu, B; Wu, G; Yang, C; Yang, K; Zhang, H; Zhou, X, 2017
)
3.34
"Cardamonin has previously demonstrated that it had an antiproliferative effect on vascular smooth muscle cells by inhibiting the activity of mammalian target of rapamycin (mTOR). "( mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion.
Chen, Y; Deng, J; Fang, Q; Niu, P; Shi, D; Tang, Y, 2014
)
2.17
"Cardamonin has promising potential in cancer prevention and therapy by interacting with proteins and modifying the expressions and activities, including factors of cell survival, proliferation, and angiogenesis. "( Cardamonin Regulates miR-21 Expression and Suppresses Angiogenesis Induced by Vascular Endothelial Growth Factor.
Ding, B; Ding, XH; Ding, ZS; Jiang, FS; Jin, B; Lu, JJ; Qian, CD; Tian, SS, 2015
)
3.3
"Cardamonin has a protective effect against acetic acid-induced colitis. "( Protective effect of cardamonin against acetic acid-induced ulcerative colitis in rats.
Abd Al Haleem, EN; Ali, AA; Khaleel, SA; Sallam, AS, 2017
)
2.22

Treatment

Pre-treatment with cardamonin significantly attenuated the nephrotoxic effects, oxidative stress and inflammation induced by cisplatin. Cardamonin treatment resulted in an apoptosis-mediated increase in cytotoxicity towards tumor cells.

ExcerptReferenceRelevance
"Cardamonin treatment resulted in an apoptosis-mediated increase in cytotoxicity towards tumor cells, a decrease in their proliferation rate, and a lowered invasive capacity, whereas the viability of melanocytes and fibroblasts was hardly affected at such concentrations."( In vitro selective cytotoxicity of the dietary chalcone cardamonin (CD) on melanoma compared to healthy cells is mediated by apoptosis.
Aplak, E; Berning, L; Brenneisen, P; Reichert, AS; Scharf, L; Stahl, W; Stucki, D; von Montfort, C, 2019
)
1.48
"Cardamonin treatment inhibited lipid droplet accumulation and reduced the expression of the adipogenic proteins C/EBPα and FABP4, and the lipogenic proteins LPAATθ, lipin 1, DGAT1, SREBP1, and FAS. "( Cardamonin suppresses lipogenesis by activating protein kinase A-mediated browning of 3T3-L1 cells.
Chei, S; Jin, H; Lee, BY; Lee, K; Oh, HJ; Oh, JH; Seo, YJ; Song, JH, 2019
)
3.4
"Cardamonin treatment inhibited the tumor incidence, tumor multiplicity, Ki-67 and β-catenin positive cells."( Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression.
Aparna, JS; Binu, VS; Harikumar, KB; James, S; Lankadasari, MB; Mohammed, S; Paul, AM; Reshmi, G; Santhoshkumar, TR, 2017
)
2.62
"Treatment with cardamonin could be a promising strategy in patients with hepatic I/R injury in different clinical situations."( Effect of cardamonin on hepatic ischemia reperfusion induced in rats: Role of nitric oxide.
Abdel-Mottaleb, Y; Atef, Y; El-Fayoumi, HM; Mahmoud, MF, 2017
)
1.2
"Treatment with cardamonin, MI mice displayed that heart hypertrophy and heart dysfunction were alleviated, and cardiac fibrosis, cardiomyocyte size and cell apoptosis of border area were decreased (P<0.05)."( Cardamonin protects against adverse cardiac remodeling through mTORC1 inhibition in mice with myocardial infarction.
Wu, X; Wu, Z; Ye, F; You, W, 2018
)
2.26
"Pre-treatment with cardamonin significantly attenuated the nephrotoxic effects, oxidative stress and inflammation induced by cisplatin, in a dose-dependent manner."( Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis.
El-Naga, RN, 2014
)
1.05
"Treated with cardamonin, the proliferation of A549 cells was inhibited. "( mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion.
Chen, Y; Deng, J; Fang, Q; Niu, P; Shi, D; Tang, Y, 2014
)
1.1
"Treated with cardamonin, the proliferation, invasion and migration of LLC cells were significantly inhibited."( Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity.
Chen, YY; Deng, J; Liu, Y; Niu, PG; Shi, DH; Zhang, YX, 2015
)
2.21

Bioavailability

ExcerptReferenceRelevance
" Following oral dose, cardamonin showed peak serum concentration that occurred at ∼2 h with very low bioavailability in both male (0."( Gender-related pharmacokinetics and bioavailability of a novel anticancer chalcone, cardamonin, in rats determined by liquid chromatography tandem mass spectrometry.
Jaiswal, S; Lal, J; Sharma, A; Shukla, M, 2015
)
0.96
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
chalconesA ketone that is 1,3-diphenylpropenone (benzylideneacetophenone), ArCH=CH(=O)Ar, and its derivatives formed by substitution.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency44.66840.631035.7641100.0000AID504339
LuciferasePhotinus pyralis (common eastern firefly)Potency21.33130.007215.758889.3584AID588342
TDP1 proteinHomo sapiens (human)Potency14.58100.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency22.38720.180013.557439.8107AID1460
thioredoxin glutathione reductaseSchistosoma mansoniPotency50.11870.100022.9075100.0000AID485364
Smad3Homo sapiens (human)Potency21.27150.00527.809829.0929AID588855; AID720534; AID720536
67.9K proteinVaccinia virusPotency22.38720.00018.4406100.0000AID720579
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency70.79460.707936.904389.1251AID504333
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency50.11873.548119.542744.6684AID743266
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency14.12540.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency10.00000.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency8.91250.00798.23321,122.0200AID2551
gemininHomo sapiens (human)Potency21.14460.004611.374133.4983AID624296; AID624297
VprHuman immunodeficiency virus 1Potency14.12541.584919.626463.0957AID651644
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)Potency10.00000.058010.694926.6086AID602310
neuropeptide S receptor isoform AHomo sapiens (human)Potency12.58930.015812.3113615.5000AID1461
Rap guanine nucleotide exchange factor 3Homo sapiens (human)Potency70.79466.309660.2008112.2020AID720709
Guanine nucleotide-binding protein GHomo sapiens (human)Potency35.48131.995325.532750.1187AID624288
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Potassium voltage-gated channel subfamily A member 3Homo sapiens (human)IC50 (µMol)0.37100.00203.19698.0000AID539299; AID539300
Genome polyproteinDengue virus 2 Thailand/16681/84Ki377.00005.80005.80005.8000AID265726
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (30)

Processvia Protein(s)Taxonomy
angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
adaptive immune responseRap guanine nucleotide exchange factor 3Homo sapiens (human)
signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayRap guanine nucleotide exchange factor 3Homo sapiens (human)
associative learningRap guanine nucleotide exchange factor 3Homo sapiens (human)
Rap protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of actin cytoskeleton organizationRap guanine nucleotide exchange factor 3Homo sapiens (human)
negative regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
intracellular signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of GTPase activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of angiogenesisRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of protein export from nucleusRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of stress fiber assemblyRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
positive regulation of syncytium formation by plasma membrane fusionRap guanine nucleotide exchange factor 3Homo sapiens (human)
establishment of endothelial barrierRap guanine nucleotide exchange factor 3Homo sapiens (human)
cellular response to cAMPRap guanine nucleotide exchange factor 3Homo sapiens (human)
Ras protein signal transductionRap guanine nucleotide exchange factor 3Homo sapiens (human)
regulation of insulin secretionRap guanine nucleotide exchange factor 3Homo sapiens (human)
potassium ion transportPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
optic nerve developmentPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
corpus callosum developmentPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
protein homooligomerizationPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
action potentialPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
potassium ion transmembrane transportPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
renal water homeostasisGuanine nucleotide-binding protein GHomo sapiens (human)
G protein-coupled receptor signaling pathwayGuanine nucleotide-binding protein GHomo sapiens (human)
regulation of insulin secretionGuanine nucleotide-binding protein GHomo sapiens (human)
cellular response to glucagon stimulusGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
guanyl-nucleotide exchange factor activityRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
protein domain specific bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
cAMP bindingRap guanine nucleotide exchange factor 3Homo sapiens (human)
voltage-gated monoatomic ion channel activityPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
protein bindingPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
outward rectifier potassium channel activityPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
delayed rectifier potassium channel activityPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
G protein activityGuanine nucleotide-binding protein GHomo sapiens (human)
adenylate cyclase activator activityGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
cortical actin cytoskeletonRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
microvillusRap guanine nucleotide exchange factor 3Homo sapiens (human)
endomembrane systemRap guanine nucleotide exchange factor 3Homo sapiens (human)
membraneRap guanine nucleotide exchange factor 3Homo sapiens (human)
lamellipodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
filopodiumRap guanine nucleotide exchange factor 3Homo sapiens (human)
extracellular exosomeRap guanine nucleotide exchange factor 3Homo sapiens (human)
plasma membranePotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
presynaptic membranePotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
calyx of HeldPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
membrane raftPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
postsynaptic membranePotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
glutamatergic synapsePotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
voltage-gated potassium channel complexPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
axonPotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
membranePotassium voltage-gated channel subfamily A member 3Homo sapiens (human)
plasma membraneGuanine nucleotide-binding protein GHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (85)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1424438Cytotoxicity in human CCRF-CEM cells by resazurin reduction assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Recent discoveries of anticancer flavonoids.
AID449996Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase at 9.3 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID265722Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 400 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID450010Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL/human recombinant DR5/Fc chimera protein2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1228814Activation of JNK2 in human HCT116 cells assessed as phosphorylation at 10 uM after 24 hrs by Western blotting analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228811Antiproliferative activity against human HCT116 cells transfected with shRNA against p53 at 10 uM after 24 hrs by CCK8 assay relative to control2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID449998Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as late apoptotic cells at 9.3 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID449992Decrease in Bcl-xL mRNA expression in human DLD1 cells co-transfected with Sac1 cells at 9.3 uM after 24 hrs by RT-PCR analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID539300Inhibition of human voltage-gated potassium channel Kv1.3 expressed in L929 cells by whole-cell patch clamp assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1.
AID1228801Induction of cell cycle arrest in human HCT116 cells assessed as cells accumulation at G0/G1 phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 31.9 +/- 2.3%)2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1752874Inhibition of Schistosoma mansoni ATPDase1 at 40 uM preincubated for 30 mins followed by addition of ATP/ADP by spectrophotometric method relative to control2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID449991Effect on c-FLIP protein expression in human DLD1 cells co-transfected with Sac1 cells after 24 hrs by Western blot analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1228817Activation of JNK1 in human HCT116 cells assessed as phosphorylation at 10 uM after 24 hrs by Western blotting analysis in presence of 30 uM PFT-alpha p53 antagonist2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID539299Inhibition of human voltage-gated potassium channel Kv1.3 expressed in CGE22 cells by patch clamp assay2010Bioorganic & medicinal chemistry letters, Dec-01, Volume: 20, Issue:23
N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1.
AID450009Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL/caspase 9 inhibitor2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1228816Activation of JNK2 in human HCT116 cells transfected with shRNA against p53 assessed as phosphorylation at 10 uM after 24 hrs by Western blotting analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID265726Inhibition of dengue2 virus NS3 protease2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID1228812Antiproliferative activity against human HCT116 cells transfected with shRNA against p53 at 10 uM after 24 hrs by CCK8 assay in presence of exogenous p53 gene2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228808Induction of autophagy in human HCT116 cells assessed as increase in LC3-II dots per cell at 10 uM upto 20 hrs by Confocal imaging analysis relative to vehicle treated control (Rvb = 0.8/cell)2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID450008Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL/z-IETD-fmk caspase 8 inhibitor2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID265719Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 120 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID399389Antiplatelet activity in human whole blood assessed as inhibition of arachidonic acid-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID1228820Antiproliferative activity against human HCT116 cells at 10 uM upto 20 hrs by CCK8 assay relative to control in presence of 20 uM SP600125 reversible JNK inhibitor2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228805Induction of autophagy in human HCT116 cells assessed as autophagic vacuoles at 10 uM after 24 hrs by monodansylcadaverine staining assay in presence of Bafilomycin A12015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228800Antiproliferative activity against human HCT116 cells assessed as cell viability at 10 uM after 24 hrs by WST8 assay relative to vehicle treated control2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID449990Induction of DR4 gene expression in human DLD1 cells co-transfected with Sac1 cells after 24 hrs by RT-PCR analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID449997Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID310873Inhibition of HIV1 protease2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
A review of anti-infective and anti-inflammatory chalcones.
AID449993Decrease in Bcl-xL mRNA expression in human DLD1 cells co-transfected with Sac1 cells at 18.5 uM after 24 hrs by RT-PCR analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID450006Decrease in procaspase 8 in TRAIL-resistant human DLD1 cells co-transfected with Sac1 cells at 18.5 uM by Western blot analysis in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID450011Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL/human recombinant DR4/Fc chimera protein2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID450003Induction of apoptosis in TRAIL-resistant human AGS cells assessed as early apoptotic cells at 9.3 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID450012Increase in CHOP mRNA expression in human DLD1 cells co-transfected with Sac1 cells2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1228819Induction of autophagy in human HCT116 cells assessed as LC3-II accumulation at 10 uM upto 20 hrs by Western blotting analysis in presence of 20 uM SP600125 reversible JNK inhibitor2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228806Induction of autophagy in human HCT116 cells assessed as increase in LC3-II accumulation at 10 uM upto 20 hrs by immunoblot analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228807Induction of autophagy in human HCT116 cells assessed as increase in LC3-II accumulation at 10 uM upto 20 hrs by Confocal imaging analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1752767Antischistosomal activity against Schistosoma mansoni BH assessed as extensive tegumental alteration at 25 uM measured after 24 hrs by light microscopy relative to control2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID399390Antiplatelet activity in human whole blood assessed as inhibition of ristocetin-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID449987Induction of DR5 protein expression in human DLD1 cells co-transfected with Sac1 cells after 24 hrs by Western blot analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID450005Induction of apoptosis in TRAIL-resistant human AGS cells assessed as early apoptotic cells at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID450000Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as late apoptotic cells at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1228803Induction of cell cycle arrest in human HCT116 cells assessed as cells accumulation at G2/M phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 19.2 +/- 0.3%)2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228799Antiproliferative activity against human HCT116 cells assessed as cell viability after 24 hrs by WST8 assay2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID449995Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as accumulation in sub-G1 phase after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID449983Induction of DR5 receptor promotor activity in human DLD1 cells co-transfected with Sac1 cells at 18.5 uM after 24 hrs by luciferase assay2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID310859Inhibition of HIV1 protease at 50 ug/mL2007European journal of medicinal chemistry, Feb, Volume: 42, Issue:2
A review of anti-infective and anti-inflammatory chalcones.
AID1228804Induction of autophagy in human HCT116 cells assessed as autophagic vacuoles at 10 uM after 24 hrs by monodansylcadaverine staining assay2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID449988Induction of DR5 gene expression in human DLD1 cells co-transfected with Sac1 cells at 9.3 uM after 24 hrs by RT-PCR analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID399387Antiplatelet activity in human whole blood assessed as inhibition of collagen-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID1228810Induction of autophagy in human HCT116 cells assessed as LC3-II accumulation at 10 uM upto 20 hrs by Western blotting analysis in presence of 30 uM PFT-alpha p53 antagonist2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228802Induction of cell cycle arrest in human HCT116 cells assessed as cells accumulation at S phase at 10 uM after 24 hrs by propidium iodide staining-based flow cytometry (Rvb = 48.8 +/- 1.5%)2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1395333Antileishmanial activity against Leishmania amazonensis MHOM/BR/76/LTB-012 axenic amastigotes after 72 hrs by MTT dye based assay2018European journal of medicinal chemistry, Apr-25, Volume: 150A comprehensive review of chalcone derivatives as antileishmanial agents.
AID449999Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as early apoptotic cells at 9.3 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1487644Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production pretreated for 30 mins followed by LPS stimulation for 12 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Flavonoid glycosides from Barringtonia acutangula.
AID449994Decrease in Bcl-xL protein expression in human DLD1 cells co-transfected with Sac1 cells after 24 hrs by Western blot analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1752875Inhibition of Schistosoma mansoni ATPDase1 preincubated for 30 mins followed by addition of ATP/ADP by spectrophotometric method2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID450004Induction of apoptosis in TRAIL-resistant human AGS cells assessed as late apoptotic cells at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID311568Cytotoxicity against human PANC1 cells assessed as cell viability2007Journal of natural products, Oct, Volume: 70, Issue:10
Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium.
AID450001Induction of apoptosis in TRAIL-resistant human DLD1 cells assessed as early apoptotic cells at 18.5 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID265721Inhibition of dengue2 virus NS2B/NS3 protease activity for Boc-Gly-Arg-Arg-MCA cleavage at 240 ppm2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease.
AID450002Induction of apoptosis in TRAIL-resistant human AGS cells assessed as late apoptotic cells at 9.3 uM after 24 hrs using annexin-V-FITC/propidium iodide staining by flow cytometry in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID449989Induction of DR5 gene expression in human DLD1 cells co-transfected with Sac1 cells at 8.5 uM after 24 hrs by RT-PCR analysis2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID1434250Inhibition of LPS-induced NO production in mouse RAW264.7 cells pretreated for 30 mins followed by LPS challenge measured after 12 hrs by Griess assay2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
Triterpene saponins and megastigmane glucosides from Camellia bugiamapensis.
AID1752765Antischistosomal activity against Schistosoma mansoni BH assessed as worm mortality at 25 uM measured after 24 hrs by light microscopy relative to control2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID1228809Induction of autophagy in human HCT116 cells transfected with shRNA against p53 assessed as LC3-II accumulation at 10 uM after 24 hrs by Western blotting analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1228813Activation of JNK1 in human HCT116 cells assessed as phosphorylation at 10 uM after 24 hrs by Western blotting analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID399388Antiplatelet activity in human whole blood assessed as inhibition of ADP-induced platelet aggregation at 100 ug/mL relative to control1998Journal of natural products, Jan, Volume: 61, Issue:1
A new antiplatelet diarylheptanoid from Alpinia blepharocalyx.
AID1228815Activation of JNK1 in human HCT116 cells transfected with shRNA against p53 assessed as phosphorylation at 10 uM after 24 hrs by Western blotting analysis2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID1752766Antischistosomal activity against Schistosoma mansoni BH assessed as reduction in motor activity at 25 uM measured after 24 hrs by light microscopy relative to control2020RSC medicinal chemistry, Apr-01, Volume: 11, Issue:4
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
AID1228818Activation of JNK2 in human HCT116 cells assessed as phosphorylation at 10 uM after 24 hrs by Western blotting analysis in presence of 30 uM PFT-alpha p53 antagonist2015Bioorganic & medicinal chemistry letters, Jun-15, Volume: 25, Issue:12
Cardamonin induces autophagy and an antiproliferative effect through JNK activation in human colorectal carcinoma HCT116 cells.
AID450007Activation of caspase 3 in TRAIL-resistant human DLD1 cells co-transfected with Sac1 cells by luminescent assay in presence of TRAIL2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
AID449986Cytotoxicity against human DLD1 cells co-transfected with Sac1 after 24 hrs2009Bioorganic & medicinal chemistry, Sep-15, Volume: 17, Issue:18
Death receptor 5 promoter-enhancing compounds isolated from Catimbium speciosum and their enhancement effect on TRAIL-induced apoptosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (142)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (0.70)18.2507
2000's19 (13.38)29.6817
2010's84 (59.15)24.3611
2020's38 (26.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.09 (24.57)
Research Supply Index4.98 (2.92)
Research Growth Index6.29 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.69%)5.53%
Reviews8 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other135 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]